[Effect of bezafibrate on disorders of lipid metabolism].
D000328:Adult; D000368:Aged; D001629:Bezafibrate / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy; D006951:Hyperlipoproteinemias / Q000188:drug therapy; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D001629:Bezafibrate
Wpływ bezafibratu na zaburzenia gospodarki tłuszczowej.